Taxotere 20mgA panel of judges has ordered all federal Taxotere lawsuits involving claims of permanent hair loss (“alopecia”) and balding to be consolidated into a multidistrict litigation (MDL) in the Eastern District of Louisiana before Judge Lance M. Africk.
Free Confidential Lawsuit Evaluation: If you suffered permanent hair loss, alopecia or balding after chemotherapy with Taxotere, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

October 6, 2016 – At least 33 Taxotere lawsuits pending in 16 federal jurisdictions will immediately be transferred into the MDL, according to Law360. Another 56 complaints in 26 districts could be eligible for transfer to Louisiana in the near future. The formation of the MDL will allow these lawsuits, as well as any filed in the future, to undergo coordinated pretrial proceedings, thereby avoiding duplicative discovery and inconsistent rulings from different judges.
Taxotere (generic: docetaxel) was approved by the FDA in June 1996 for the treatment of breast cancer. The drug’s approval was later expanded to include head and neck cancer, gastric cancer, prostate cancer and non-small cell lung cancer.
However, it was only in December 2015 that the U.S. label’s “Adverse Events” section was changed to indicate that cases of permanent hair loss or alopecia had been reported in cancer patients treated with the drug.
Plaintiffs allege that Taxotere is more likely to cause permanent alopecia than equally effective chemo drugs on the market, and that Sanofi warned about this risk in other countries, including Canada and the European Union (EU). In the U.S., however, the drug’s labeling merely states that “hair generally grows back” after chemotherapy with Taxotere is complete.
In July, two plaintiffs filed a request with the U.S. Judicial Panel on Multidistrict Litigation (JPML) seeking centralization of all federal Taxotere lawsuits in the Eastern District of Louisiana. Sanofi argued that New Jersey was the appropriate venue; however, JPML sided with the plaintiffs. The litigation is In Re: Taxotere (Docetaxel) Products Liability Litigation – MDL No. 2740).

Do I Have a Taxotere Lawsuit?

The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Taxotere lawsuits. We are handling individual litigation nationwide and currently accepting new hair loss and alopecia cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one was injured by Taxotere side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

FREE Confidential Case Evaluation

To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.